Export

ATC codes: A02BC01
EMLc
Indication
Gastro-oesophageal reflux disease ICD11 code: DA22.Z
INN
Omeprazole
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Oral > Liquid: 20 mg powder for oral liquid ; 40 mg powder for oral liquid
Oral > Solid: 10 mg ; 20 mg ; 40 mg
EML status history
First added in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup A02BC Proton pump inhibitors (excluding combinations)
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup A02BC Proton pump inhibitors (excluding combinations)
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that medicines in 4th level ATC chemical subgroup, A02BC Proton pump inhibitors (excluding combinations), be specified as therapeutic alternatives under the square box listing for omeprazole on the EML and EMLc.